BioNxt Solutions Inc. XPHYF
Set alert
0.28 +0.28 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
News
- BioNxt Solutions Announces Closing of Shares for Debt Settlement
- Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt
- BioNxt's Sublingual Cladribine Program for MS Ready for Next Phase
- Bionxt Solutions Provides Bi-Weekly MCTO Status Report
- BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement
- BioNxt Solutions Announces Closing of Third and Final Tranche of Non-Brokered Private Placement
- BioNxt Solutions Announces Change of Directors
- XPhyto Therapeutics says director and founder Professor Dr Raimar Loebenberg receives leadership award from Canadian Society for Pharmaceutical Science
- XPhyto Therapeutics says pharmaceutical manufacturing expert Dr Florian A. Sahr has joined its European operations as project management head
- XPhyto Therapeutics advancing Rotigotine transdermal patch towards final pivotal study in fourth quarter this year
Your note
Sign in to keep a note on XPHYF — it syncs with the Stock Master app.